Keywords: new, indication, approval, ciba, aredia, pharmaceutical, pamidronate

New Indication Approval For Ciba's Aredia

Article | 15 July 1996

- Ciba Pharmaceutical's Aredia (pamidronate disodium) has been approved in a new indication for the treatment of osteolytic bone metastases and ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Drugs

Aredia

Pamidronate Disodium

Go to drug listing